Moesin-associated immunodeficiency study
Part of Immune system & allergy, Infections clinical trials.
This study looks at a rare immune system condition caused by changes in the MOESIN gene. It aims to better understand the condition and may help develop future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are male.
- You have a confirmed change (mutation) in the MOESIN gene, also called MSN.
- You do not object to your personal health data being collected for the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at genetic diseases that affect the immune system and the brain. It aims to better understand these conditions by comparing patients, their relatives, and healthy controls.
This study looks for genetic causes of immune problems, such as unusually frequent infections, abnormal allergies, or autoimmune or inflammation conditions. It may help by improving how doctors understand these disorders and by matching families with possible genetic diagnoses.
This study follows people with or at risk for MEHMO syndrome over time to better understand the condition and identify biological markers. It may include both affected individuals and their family members to see how the condition runs in families.
This study looks at how the body fights mycobacterial infections (a type of bacteria) and aims to find immune problems that make some people more prone to these infections. It may help us understand why some people get sick and could lead to better treatments.
This study screens people who may have an inherited immune system condition (like problems with immune cell growth or death) and their blood relatives. The goal is to understand the condition better by collecting blood samples for testing.
This study looks at how immune system problems relate to fungal infections, using medical records and lab tests on blood and tissue. It may help researchers understand the cause of these infections—especially for people with inherited immune conditions—and improve future care.
Hear when a new Immune Deficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.